Changing the Course of a Pandemic
The work of researchers at Children’s and Emory has helped change the course of the COVID-19 pandemic. We were on the forefront of COVID-19 research that allowed for the gradual return to everyday life by leading to authorization of pediatric vaccines, availability of at-home tests, authorization of new drugs for treatment, assessing antibodies and variants, and identification of potential biomarkers. These discoveries have helped. Kids are back in the classroom and participating in social activities in person once again—and it was all made possible, in part, by discoveries made in our labs and clinics.
Testing a Pill to Treat Kids at High Risk for Severe COVID-19
Children’s and Emory are participating in a global trial testing the Pfizer oral anti-viral medication, Paxlovid, in children under age 18.
Children's Study Shows Evidence of COVID-19 and MIS-C Biomarker
Increased levels of plasma osteopontin were observed in patients with COVID-19 and multi-system inflammatory condition in children (MIS-C).
Children’s and Emory Launch Moderna COVID-19 Vaccine Trial
The trial will test the Moderna COVID-19 vaccine in children ages 6 months to less than 12 years.
Unprecedented Discoveries, Global Impact
Researchers at Children’s and Emory have shown what it takes to combat a pandemic. Unprecedented discoveries in COVID-19 have had a global impact while our standard research program has continued to achieve significant milestones, including a $31 million grant for the Marcus Center for Pediatric Cellular Therapies.Read Our Research Report
Receive our latest research and innovation updates straight to your inbox.
Research into COVID-19 is ongoing, with new discoveries coming at an unprecedented pace. To stay on top of research advancements at Children’s, sign up for our updates.SUBSCRIBE